ChemicalBook >> CAS DataBase List >>Navivumab
Navivumab
- CAS No.
- 1443004-16-7
- Chemical Name:
- Navivumab
- Synonyms
- Navivumab;Navivumab (anti-HA);Research Grade Navivumab;Research Grade Navivumab (DVV03803)
- CBNumber:
- CB08080938
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MOL File:
- Mol file
- MSDS File:
- SDS
- TDS File:
- TDS
Last updated:2026-04-24 14:58:55
| form | Liquid |
|---|---|
| color | Colorless to light yellow |
| FDA UNII | T03CDT3SDM |
Navivumab price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0629156 | Navivumab 99.10% | 1443004-16-7 | 1mg | $325 | 2026-06-04 | Buy |
| ChemScene | CS-0629156 | Navivumab 99.10% | 1443004-16-7 | 5mg | $845 | 2026-06-04 | Buy |
| ChemScene | CS-0629156 | Navivumab 99.10% | 1443004-16-7 | 10mg | $1354 | 2026-06-04 | Buy |
| aablocks | AA02ANXC | Navivumab ≥95%(SDS-PAGE&SEC-HPLC) | 1443004-16-7 | 1mg | $514 | 2026-06-02 | Buy |
| aablocks | AA02ANXC | Navivumab ≥95%(SDS-PAGE&SEC-HPLC) | 1443004-16-7 | 5mg | $1334 | 2026-06-02 | Buy |
Navivumab Chemical Properties, Uses, Production
Uses
Navivumab (CT-P23) is an influenza A virus hemagglutinin HA monoclonal antibody. neutralizes H1, H2, H5, and H9 influenza A viruses by binding to the stem fusion domain in HA2[1].
References
[1] Beigel JH. Polyclonal and monoclonal antibodies for the treatment of influenza. Curr Opin Infect Dis. 2018 Dec;31(6):527-534. DOI:10.1097/QCO.0000000000000499
Navivumab Preparation Products And Raw materials
Raw materials
Preparation Products
Navivumab Suppliers
Global Suppliers ( 17)
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| ShangHai Biochempartner Co.,Ltd | 177-54423994 17754423994 | 2853530910@QQ.com | China | 8000 | 62 |
| Guangzhou Hongyuan Chemical Co.,Ltd | 15817493340 | 981810490@qq.com | China | 1577 | 58 |
| Wuhan Chemstan Biotechnology Co., Ltd. | 027-65317797 15926423062 | 422450190@qq.com | China | 10305 | 58 |
| Beijing Jin Ming Biotechnology Co., Ltd. | 010-60605840 | psaitong@jm-bio.com | China | 27626 | 58 |
| Biolab Reagents | 027-65279366 18108604356 | products@biolabreagent.com | China | 9864 | 58 |
| Wuhan Jingkangen Biomedical Technology Co., Ltd | 13720134139 086-15871494362 13720134139 | orders@jknbiochem.com | China | 7283 | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 11963 | 58 |
| Wuhan Acumen Bio-Technology Co.,ltd | 027-027-16602739303 16602739303 | 673003916@qq.com | China | 4593 | 58 |
| Changsha Fuzhen Biotechnology Co.,LTD | 15111215862 18229892877 | 3062105966@qq.com | China | 5569 | 58 |
1443004-16-7 (Navivumab) Related Search:
Navivumab
Research Grade Navivumab (DVV03803)
Research Grade Navivumab
Navivumab (anti-HA)
1443004-16-7




